Wednesday , December 8 2021

Tag Archives: capsules

Dr. Reddy’s Lab launches Atomoxetine Capsules in US market

Dr. Reddy’s Laboratories has launched Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in the United States market approved by the US Food and Drug Administration (USFDA). The Strattera brand and generic had US sales of approximately $304 million MAT for the most recent twelve months ... Read More »

Strides’ arm receives USFDA’s approval for Gabapentin Capsules

Strides Pharma Science’s step‐down wholly owned subsidiary, Strides Pharma Global Pte, has received approval for Gabapentin Capsules USP, 100 mg, 300 mg, and 400 mg from the United States Food and Drug Administration (USFDA). Gabapentin Capsules is a generic version of Neurontin Capsules of Pfizer. The product received approval in ... Read More »